Multiple sclerosis and the Epstein Barr virus
Inside Health
00:00
Eb v Vaccine
We don't have a sterilizing vaxcine. We'll have to target people before they become infected of the virus. There's more interest now since the asera paper launched, and we've had about two or three companies get interested in e b v vaxine. So i'm very excited by the fact that the big vaccine companies are getting interested in making the n b b vaccine,. But i think we can have to use the vaccine as a treatment strategy rather than just develop a vaccine.
Transcript
Play full episode
